{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:05:48Z","timestamp":1791187548968,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.neurol.2011.07.010","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T23:42:25Z","timestamp":1323214945000},"page":"143-151","source":"Crossref","is-referenced-by-count":7,"title":["Troubles du contr\u00f4le des impulsions associ\u00e9s \u00e0 la maladie de Parkinson\u00a0: \u00e9tude d\u2019une cohorte de 35\u00a0patients"],"prefix":"10.1016","volume":"168","author":[{"given":"N.","family":"Carri\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kreisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dest\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2011.07.010_bib0005","series-title":"DSM-IV-TR Manuel diagnostique et statistique des troubles mentaux\u00a0: Texte r\u00e9vis\u00e9","author":"American Psychiatric Association","year":"2003"},{"key":"10.1016\/j.neurol.2011.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":"Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation","volume":"21","author":"Ardouin","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0015","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of pathological gambling in patients with Parkinson's disease","volume":"21","author":"Avanzi","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neurol.2008.02.035","volume":"164","author":"Azulay","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.parkreldis.2007.11.008","article-title":"Topiramate in managing impulse control disorders in Parkinson's disease, Parkinsonism","volume":"14","author":"Bermejo","year":"2008","journal-title":"Relat Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00415-010-5603-7","article-title":"Zonisamide in managing impulse control disorders in Parkinson's disease","volume":"257","author":"Bermejo","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0317167100010489","article-title":"Outcomes of patients with Parkinson disease and pathological gambling","volume":"37","author":"Bharmal","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2011.07.010_bib0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S1092852900020630","article-title":"Compulsive buying disorder: a review of the evidence","volume":"12","author":"Black","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.neurol.2011.07.010_bib0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neurol.2008.01.002","article-title":"Syndrome de dysr\u00e9gulation dopaminergique dans la maladie de Parkinson","volume":"164","author":"Borg","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","article-title":"Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease","volume":"84","author":"Bostwick","year":"2009","journal-title":"Mayo Clin. Proc"},{"key":"10.1016\/j.neurol.2011.07.010_bib0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0060","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.07.010_bib0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.22505","article-title":"Impulsive and compulsive behaviors in Parkinson's disease","volume":"24","author":"Evans","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0070","series-title":"Recent developments in Parkinson's disease","first-page":"153","article-title":"Unified parkinson's Disease Rating Scale","author":"Fahn","year":"1986"},{"key":"10.1016\/j.neurol.2011.07.010_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u00ab\u00a0Mini-mental state\u00a0\u00bb. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neurol.2011.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/mds.22652","article-title":"Managing pathological gambling in Parkinson's disease with enteral levodopa\/carbidopa infusions","volume":"24","author":"Gerschlager","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2990.1989.tb01147.x","article-title":"The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease","volume":"15","author":"Gibb","year":"1989","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.neurol.2011.07.010_bib0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","article-title":"Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease","volume":"16","author":"Lee","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0100","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of DRD3\u00a0and GRIN2B with impulse control and related behaviors in Parkinson's disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0105","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/mds.22824","article-title":"Clinical follow-up of pathological gambling in Parkinson's disease in the West Scotland study","volume":"24","author":"Macphee","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0115","first-page":"242","article-title":"Compulsive buying: a report of 20\u00a0cases","volume":"55","author":"McElroy","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neurol.2011.07.010_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2010.06.002","article-title":"From the cell to the clinic: a comparative review of the partial D2\/D3\u00a0receptor agonist and \u03b12-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease","volume":"128","author":"Millan","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neurol.2011.07.010_bib0125","first-page":"CD001521","article-title":"WITHDRAWN: interventions for pathological gambling","author":"Oakley-Browne","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2011.07.010_bib0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0135","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.23147","article-title":"Decreased ventral striatal activity with impulse control disorders in Parkinson's disease","volume":"25","author":"Rao","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0140","doi-asserted-by":"crossref","first-page":"e2479","DOI":"10.1371\/journal.pone.0002479","article-title":"Dopamine agonist increases risk taking but blunts reward-related brain activity","volume":"3","author":"Riba","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2011.07.010_bib0145","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.23177","article-title":"Clozapine for medication-related pathological gambling in Parkinson disease","volume":"25","author":"Rotondo","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2010.02.006","article-title":"Long term follow-up of Parkinson's disease patients with impulse control disorders","volume":"16","author":"Sohtao\u011flu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0155","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2011.07.010_bib0160","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.neurol.2010.07.006","article-title":"Maladie de Parkinson\u00a0: de la physiopathologie des troubles psychiques \u00e0 la ma\u00eetrise du traitement dopaminergique","volume":"166","author":"Thobois","year":"2010","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2011.07.010_bib0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0170","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.22453","article-title":"Psychotic and compulsive symptoms in Parkinson's disease","volume":"24","author":"Verbaan","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0175","series-title":"La maladie de Parkinson","first-page":"151","article-title":"Strat\u00e9gies m\u00e9dicamenteuses antiparkinsoniennes","author":"V\u00e9rin","year":"2006"},{"key":"10.1016\/j.neurol.2011.07.010_bib0180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.07.010_bib0185","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.07.010_bib0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuron.2009.12.027","article-title":"Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors","volume":"65","author":"Voon","year":"2010","journal-title":"Neuron"},{"issue":"S3","key":"10.1016\/j.neurol.2011.07.010_bib0200","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S1353-8020(09)70794-1","article-title":"Impulse control disorders in Parkinson's disease: prevalence and possible risk factors","volume":"15","author":"Weintraub","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2011.07.010_bib0205","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090\u00a0patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0215","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2011.07.010_bib0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WNF.0b013e3181684542","article-title":"Impulse control disorders arising in 3\u00a0patients treated with rotigotine","volume":"32","author":"Wingo","year":"2009","journal-title":"Clin Neuropharmacol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T10:19:35Z","timestamp":1593339575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0035378711003754"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.07.010","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}